YENOM NOTICIAS

Qué está moviendo el mercado.

Noticias financieras organizadas para conectar titulares, símbolos, fuente, fecha y sentimiento con tu análisis y operativa.

DUNK
Limpiar

Si escribes ticker, YENOM prioriza ese instrumento. Si lo dejas vacío puedes explorar el feed general o por tema.

finance.yahoo.comPOSITIVO

Should You Tap Snowflake's Post-Earnings Rally Via ETFs?

In early September,Snowflake SNOW reported second-quarter fiscal 2027 non-GAAP earnings of 62 cents per share, up 77.1% year over year andsurpassing the Zacks Consensus Estimate by 37.78%. Revenues of $1.55 billion increased 35.1% and beat…

finance.yahoo.comPOSITIVO

Snowflake Surges on Upbeat Earnings: ETFs in Focus

Snowflake Inc. SNOW reported adjusted quarterly earnings of $0.39 per share on Wednesday, beating the Zacks Consensus Estimate of $0.32 per share. This compares to earnings of $0.24 per share a year ago. The company posted revenues of $1.3…

seekingalpha.comPOSITIVO

ETFs with high Snowflake exposure in spotlight after earnings rally

[Snowflake corporate headquarters in Silicon Valley] Sundry Photography/iStock Editorial via Getty Images Snowflake (SNOW [https://seekingalpha.com/symbol/SNOW]) surged 38% in premarket trading Thursday after the cloud data company deliver…

finance.yahoo.comPOSITIVO

Amazon Chip Division Hit By Second Senior Exit In Months

Amazon.com Inc. is navigating another senior exit from its Annapurna Labs chip division, raising questions about leadership continuity as it scales its Trainium AI chips to compete with Nvidia Corp.. Leadership Changes at Annapurna Labs Ga…

finance.yahoo.comPOSITIVO

Ryan Gosling's 'Project Hail Mary' Smashes Records For Amazon Prime Video

Amazon.com, Inc is sharpening its entertainment strategy by pairing theatrical success with higher monetization on its streaming platform. Box Office Win Signals Film Strategy Shift Amazon has scored its first major theatrical hit a decade…

finance.yahoo.comPOSITIVO

Eli Lilly's Experimental Cancer Drug Cuts Recurrence Risk In Early-Stage Lung Cancer Patients

Eli Lilly and Co.(NYSE:LLY) on Monday shared positive topline results from the Phase 3 LIBRETTO-432 clinical trial for Retevmo (selpercatinib). The trial demonstrated a highly statistically significant improvement in event-free survival fo…

globenewswire.comPOSITIVO

Dana Investment Advisors Launches Two New ETFs: Dana Unconstrained Equity ETF (DUNK) and Dana Concentrated Dividend ETF (DIVE)

WAUKESHA, Wis., Sept. 17, 2025 (GLOBE NEWSWIRE) -- Dana Investment Advisors, Inc., a boutique asset management firm with over four decades of experience guiding investors through evolving market environments, today announced the launch of…